XML 59 R44.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE (Tables)
 12 Months Ended
Jan. 29, 2023
Earnings Per Share [Abstract]  
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

We expect to continue to grant these types of awards annually in the future. The following table sets forth the number of outstanding restricted stock awards and RSUs and PSUs, net of forfeitures and vested shares, as of the fiscal period-end dates indicated:

 

   

January 29,

    

January 30,

    

January 31,

  
   

2023

    

2022

    

2021

  
                         

Restricted shares

     132,304       59,500       54,747  

RSUs and PSUs

     100,969       77,841       140,911  
      233,273       137,341       195,658  

 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] The following table sets forth the computation of basic and diluted earnings per share:
   

Fifty-Two Weeks Ended

  
   

January 29,

    

January 30,

    

January 31,

  
   

2023

    

2022

    

2021

  
                         

Net (loss)/income

   $ (4,312 )   $ 11,718     $ (10,426 )

   Less: Dividends on unvested restricted shares

     103       46       36  

             Net earnings allocated to unvested restricted stock

     -       61       -  

Earnings available for common shareholders

   $ (4,415 )   $ 11,611     $ (10,462 )
                         

Weighted average shares outstanding for basic earnings per share

     11,593       11,852       11,822  

Dilutive effect of unvested restricted stock awards

     *       118      
*
  

   Weighted average shares outstanding for diluted earnings per share

     11,593       11,970       11,822  
                         

Basic (loss)/earnings per share

   $ (0.37 )   $ 0.99     $ (0.88 )
                         

Diluted (loss)/earnings per share

   $ (0.37 )   $ 0.97     $ (0.88 )

 

*Due to net loss in fiscal 2023 and fiscal 2021, approximately 117,000 and 119,000 shares would have been antidilutive and are therefore excluded from the calculation of earnings per share, respectively.